Title 21 of the Code of Federal Regulations (CFR) is the collection of rules that govern food, drugs, medical devices, cosmetics, tobacco products, and controlled substances in the United States. It spans nearly 1,500 parts across three federal agencies, making it one of the most referenced regulatory titles for anyone working in healthcare, pharmaceuticals, food manufacturing, or life sciences. If a product goes into or onto your body, there’s a good chance 21 CFR has rules about how it’s made, labeled, tested, and sold.
How 21 CFR Is Organized
The Code of Federal Regulations is the full set of permanent rules published by all federal agencies. It’s divided into 50 titles by subject area. Title 21, labeled “Food and Drugs,” is managed primarily by three agencies, each assigned its own chapter:
- Chapter I (Parts 1–1299): Food and Drug Administration (FDA), within the Department of Health and Human Services
- Chapter II (Parts 1300–1399): Drug Enforcement Administration (DEA), within the Department of Justice
- Chapter III (Parts 1400–1499): Office of National Drug Control Policy
The FDA’s chapter is by far the largest, broken into subchapters that cover specific product categories: food for human consumption (Parts 100–199), drugs (Parts 200–499), animal drugs and feeds (Parts 500–599), biologics like vaccines and blood products (Parts 600–680), cosmetics (Parts 700–799), medical devices (Parts 800–898), mammography standards, radiological health, and tobacco products. Each part contains detailed requirements that manufacturers, labs, and distributors must follow.
Why 21 CFR Matters
These aren’t guidelines or suggestions. They carry the force of law. When a company fails to comply with a regulation in Title 21, the FDA can issue warning letters, seize products, seek injunctions, or pursue criminal charges. Warning letters are public documents, and they commonly cite violations related to manufacturing practices, insanitary conditions, mislabeled products, and false or misleading claims. A drug manufactured outside the rules can be legally classified as “adulterated,” which means it can be pulled from the market and the responsible company or individuals held liable.
Key Parts That Come Up Most Often
Food Labeling (Part 101)
Part 101 sets the rules for everything you see on a food package. Ingredients must be listed by their common name in descending order of weight. Nutrition information is required on nearly all packaged foods intended for human consumption, displayed in a standardized format. Health claims, nutrient content claims, and allergen declarations all fall under this part. If you’ve ever checked a Nutrition Facts panel, you were reading something shaped by Part 101.
Drug Manufacturing Standards (Parts 210 and 211)
These parts establish what’s known as current Good Manufacturing Practice, or cGMP. They set the minimum standards for how drugs must be manufactured, processed, packaged, and stored to ensure safety, identity, strength, quality, and purity. Part 210 lays out the general scope, while Part 211 gets into specifics for finished drug products. The regulations cover everything from building cleanliness to equipment maintenance to quality control testing. Any drug made outside these standards is considered adulterated under federal law, regardless of whether the final product actually tests as defective.
Medical Device Quality Systems (Part 820)
Manufacturers of medical devices must maintain a documented quality management system. Part 820 now aligns with an international standard (ISO 13485) and requires procedures for device traceability, unique device identification, complaint handling, and reporting to the FDA. Manufacturers of higher-risk devices (Class II and Class III) must also follow formal design and development controls, documenting how the device was conceived, tested, and validated before it ever reaches a patient.
Electronic Records and Signatures (Part 11)
Part 11 defines when electronic records and electronic signatures can legally replace paper records and handwritten signatures. This matters enormously in industries that have moved to digital systems for batch records, lab notebooks, and regulatory submissions. To qualify, the electronic systems must meet specific criteria for trustworthiness and reliability. Records submitted to the FDA in electronic form must also be of a type the agency has agreed to accept electronically. Since August 1997, compliant electronic signatures have been considered equivalent to handwritten ones.
Controlled Substance Schedules (Part 1308)
This part falls under the DEA’s chapter and lists every controlled substance organized into five schedules. Schedule I includes substances considered to have high abuse potential and no currently accepted medical use. Schedule V includes substances with the lowest relative abuse potential. Each substance is assigned a specific code number. The DEA can add, move, or remove substances from these schedules through a formal rulemaking process that includes requesting a scientific and medical evaluation from the Secretary of Health and Human Services.
Human Subject Protections (Part 50)
Any clinical investigation regulated by the FDA must follow Part 50’s rules for protecting human participants. The core requirement is informed consent: no researcher can enroll a person in a study without first obtaining their legally effective agreement. That consent process must give participants enough time to consider their decision, free from pressure or coercion. Consent forms cannot include language that waives a participant’s legal rights or releases the researchers from liability for negligence. Participants must be told about foreseeable risks, reminded that participation is voluntary, and informed they can withdraw at any time without losing any benefits they’re otherwise entitled to.
Who Needs to Know 21 CFR
If you work in food production, pharmaceutical manufacturing, medical device development, clinical research, cosmetics, tobacco, or dietary supplements, 21 CFR directly shapes what you can and cannot do. Quality assurance teams, regulatory affairs professionals, and compliance officers reference it daily. But it also affects smaller operations: a small bakery selling packaged goods, a compounding pharmacy, or a startup developing a health app that qualifies as a medical device all fall under its reach.
The full, current text of Title 21 is freely available on the Electronic Code of Federal Regulations (eCFR) website, which is updated continuously as new rules are finalized and published in the Federal Register. The eCFR is searchable by part number, keyword, or subject, making it the most practical way to look up a specific regulation.